Prostate cancer screening in a Saudi population: An explanatory trial study

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 2, 2010, Pages 191-194

  Rabah, D M ^a   Arafa, M A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Prostate cancer; PSA; Saudi Arabia; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CANCER SCREENING; COHORT ANALYSIS; DIGITAL RECTAL EXAMINATION; HEALTH CARE FACILITY; HIGH RISK PATIENT; HUMAN; MALE; METASTASIS; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; SAUDI ARABIA;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SAUDI ARABIA; TUMOR MARKERS, BIOLOGICAL;

EID: 77952544761     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.60     Document Type: Article

References (14)

1. US Preventive Services Task Force updates Prostate Cancer Screening recommendations. 2008. http://www.acponline.org/pressroom/pcancer.htm. Accessed October 2009.
2. National Cancer Institute. Prostate cancer screening. http://www.cancer.gov/cancertopics/pdq/screening/prostate/Patient. Accessed October 2009.
3. AUA American new guidelines on prostate cancer screening. April 2009. http://www.psa-rising.com/mednews/component/content/article/38-screening/ 78-aua-new-guidelines-on-prca-screening.
4. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer 2003. CA Cancer J Clin 2003;53:27-43.
5. What does shared decision making mean for prostate screening. http://blogs.wsj.com/health/2009/09/28/what-does-shared-decisionmaking-mean-for- prostate-screening/. Accessed September 2009.
6. Ministry of Health. Saudi National Cancer Registry. Cancer Incidence Report, Saudi Arabia, 2004.
7. Vadarampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J. Factors predicting PSA testing among first degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2004;13:753-758.
8. UK prostate cancer incidence statistics. www.info.cancerresearchuk.org/ cancerstats/types/prostate/incidence/. Accessed 9/2009.
9. Evans HS, Moller H. Recent trends in in prostate cancer incidence and mortality in Southeast England. Eur Urol 2003;43(4):337-341.
10. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate cancer mortality in a randomized European study. NEJM 2009;360:1320-1328.
11. Andriole GL, Grubb RL, Crawford ED, Buys SS, Chia D, Fouad MN et al. Mortality results from a randomized prostate cancer screening trial. NEJM 2009;360(13):1310-1313.
12. Presti Jr JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000;163:163-167.
13. Philip J, Hanchanale V, Foster CS, Javle P. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. BJU Int 2006;98:559-562.
14. Djavan B, Margretier M. Biopsy standards for detection of prostate cancer world. J Urol 2007;25:11-17.